Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - GROSS PROFIT
Gross Profit RPRX - Royalty Pharma plc
1.79 B
LAST VALUE
-11.03%
2 YEAR CAGR
1.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR